The trivalent inactivated influenza vaccine (TIV) used in this study contains hemagglutinin (HA) surface glycoprotein from two influenza A strains (H1N1 and H3N2) and one influenza B strain (either Yamagata or Victoria lineage). The gene discussed is ART4; the disease is influenza.